A MULTINATIONAL STUDY TO DETERMINE INDICATORS OF SUBOPTIMAL THERAPY AMONG ULCERATIVE COLITIS PATIENTS TREATED WITH TUMOR NECROSIS FACTOR ANTAGONISTS
James Lindsay 1
Javier Gisbert 2
Reema Mody 3
Laurent Peyrin-Biroulet 4
Alessandro Armuzzi 5
Bernd Bokemeyer
Geoffrey C. Nguyen
Jean Siebenaler
Örjan Åkerborg
Michael Smyth
1 Department of Gastroenterology,Barts Health NHS Trust,London,United Kingdom
2 Hospital Universitario de La Princesa, IIS-IP and CIBEREHD,Madrid,Spain
3 Takeda Pharmaceuticals International, Inc.,Deerfield,United States
4 CHU de Nancy - Hôpital Brabois,Vandœuvre-lès-Nancy,France
5 IBD Unit,Complesso Integrato Columbus, Catholic University,R
Conference
UEG Week 2015
Citation
United European Gastroenterology Journal; 2015: 2 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]